Elbit Med Tech
Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of magnetic and focused imaging equipment in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurologica… Read more
Elbit Med Tech (EMTC) - Total Assets
Latest total assets as of December 2022: ILA25.53 Million ILA
Based on the latest financial reports, Elbit Med Tech (EMTC) holds total assets worth ILA25.53 Million ILA as of December 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Elbit Med Tech - Total Assets Trend (2008–2022)
This chart illustrates how Elbit Med Tech’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Elbit Med Tech - Asset Composition Analysis
Current Asset Composition (December 2022)
Elbit Med Tech's total assets of ILA25.53 Million consist of 8.9% current assets and 91.1% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 1.0% |
| Accounts Receivable | ILA9.00K | 0.0% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2008–2022)
This chart illustrates how Elbit Med Tech's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Elbit Med Tech's current assets represent 8.9% of total assets in 2022, an increase from 6.4% in 2008.
- Cash Position: Cash and equivalents constituted 1.0% of total assets in 2022, up from 0.1% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 0.0% of total assets.
Elbit Med Tech Competitors by Total Assets
Key competitors of Elbit Med Tech based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
InBody Co.Ltd
KQ:041830
|
Korea | ₩318.34 Billion |
|
MEDIANA Co.Ltd
KQ:041920
|
Korea | ₩147.44 Billion |
|
Value Added Technology Co. Ltd
KQ:043150
|
Korea | ₩658.61 Billion |
|
MEKICS Co Ltd
KQ:058110
|
Korea | ₩55.71 Billion |
|
Meta Biomed Co. Ltd
KQ:059210
|
Korea | ₩180.11 Billion |
|
INFINITT Healthcare Co. Ltd
KQ:071200
|
Korea | ₩229.14 Billion |
|
i-SENS Inc
KQ:099190
|
Korea | ₩583.47 Billion |
|
Sewoon Medical Co. Ltd
KQ:100700
|
Korea | ₩158.77 Billion |
Elbit Med Tech - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Elbit Med Tech generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Elbit Med Tech is currently not profitable relative to its asset base.
Elbit Med Tech - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.33 | 5.71 | 0.67 |
| Quick Ratio | 4.33 | 5.71 | 0.67 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA1.74 Million | ILA 8.02 Million | ILA -20.00K |
Elbit Med Tech - Advanced Valuation Insights
This section examines the relationship between Elbit Med Tech's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.63 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -17.9% |
| Total Assets | ILA25.53 Million |
| Market Capitalization | $3.66K USD |
Valuation Analysis
Below Book Valuation: The market values Elbit Med Tech's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Elbit Med Tech's assets decreased by 17.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Elbit Med Tech (2008–2022)
The table below shows the annual total assets of Elbit Med Tech from 2008 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | ILA25.53 Million | -17.89% |
| 2021-12-31 | ILA31.10 Million | -62.55% |
| 2020-12-31 | ILA83.03 Million | +501.83% |
| 2019-12-31 | ILA13.80 Million | -50.78% |
| 2018-12-31 | ILA28.03 Million | +31044.44% |
| 2017-12-31 | ILA90.00K | -98.38% |
| 2016-12-31 | ILA5.55 Million | -73.10% |
| 2015-12-31 | ILA20.62 Million | -38.55% |
| 2014-12-31 | ILA33.56 Million | -17.60% |
| 2013-12-31 | ILA40.73 Million | +146.52% |
| 2011-12-31 | ILA16.52 Million | -30.77% |
| 2010-12-31 | ILA23.86 Million | +43.35% |
| 2009-12-31 | ILA16.65 Million | -74.27% |
| 2008-12-31 | ILA64.69 Million | -- |